Venture Capital

VOYAGERS Health-Tech Fund

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Pre-Seed, Seed, Series A

Geographical Focus
United States, United Kingdom, Germany, Australia, Italy, Denmark, Switzerland, Spain, Kenya, Ireland, Portugal, Sweden, Belgium, Israel, Norway, Finland, Peru, Iceland, Ukraine

Industries Focus

  • Technology
  • Healthcare
  • Digital Health
  • Medtech
  • Biotechnology
  • Healthcare IT

Investment Size:
100,000 to 1,500,000 USD

Investor Details Founded: 2020

VOYAGERS Health-Tech Fund is a venture capital fund based in the United Kingdom, focusing on early-stage investments in health-tech and life sciences startups. The fund is part of the VOYAGERS community, a network of over 1,500 professionals from more than 30 countries committed to supporting each other in impactful projects. Through this community, the fund leverages extensive networks and expertise to identify and invest in startups with transformative potential in the healthcare sector.

The fund's investment strategy targets companies that are solving significant healthcare problems using innovative technology or biotechnology. It typically invests in Pre-Seed, Seed, or Series A stages, with individual investments ranging from $100,000 to $1.5 million. The geographical focus includes the United Kingdom, United States, and several other countries, reflecting the global reach of the VOYAGERS community.

Since its inception, the fund has made notable investments, including a $75,000 investment in 23 early-stage companies over a two-year period. One of its early successes was an investment in the mental-health startup Cerebral, which later raised funds at a valuation of $4.8 billion, significantly increasing the fund's initial investment. This track record demonstrates the fund's commitment to supporting innovative solutions in the health-tech sector and its ability to identify high-potential startups.

Requirements
  • Companies solving significant healthcare problems
  • Use of innovative technology or biotechnology
  • Led by mission-driven founders with strong ethics
  • Potential to become $100 million+ businesses
  • At Pre-Seed, Seed, or Series A stage
  • Fit within the VOYAGERS community
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[Email Hidden]

Portfolio Companies
  • Cerebral
  • Baseimmune
Claim this Investor

Are you an official representative of VOYAGERS Health-Tech Fund?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim